Related Experiment Video
Updated: Apr 29, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis
Patompong Ungprasert1, Prangthip Charoenpong, Praveen Ratanasrimetha
1Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, P.Ungprasert@gmail.com.
Insights
Patients with systemic sclerosis (SSc) face a significantly higher risk of developing coronary artery disease (CAD). This meta-analysis confirms a 1.82 times increased risk, highlighting a critical link between SSc and heart health.
Area of Science:
- Cardiology
- Rheumatology
- Epidemiology
Background:
- Chronic inflammatory disorders like rheumatoid arthritis and lupus increase coronary artery disease (CAD) risk.
- The association between systemic sclerosis (SSc) and CAD risk remains unclear.
Purpose of the Study:
- To systematically review and meta-analyze observational studies assessing CAD risk in patients with SSc.
- To quantify the pooled risk ratio of CAD in individuals diagnosed with SSc compared to non-SSc individuals.
Main Methods:
- Systematic review and meta-analysis of observational studies.
- Inclusion criteria: studies reporting risk estimates (OR, RR, HR, SIR) for CAD in SSc patients.
- Data synthesis using a random-effects, generic inverse variance method.
Main Results:
- Four studies were included in the analysis.
- The pooled risk ratio for CAD in patients with SSc was 1.82 (95% CI, 1.40 to 2.36).
- Moderate statistical heterogeneity was observed (I² = 73%).
Conclusions:
- Systemic sclerosis is associated with a statistically significant increased risk of coronary artery disease.
- Findings underscore the importance of cardiovascular risk assessment in SSc patients.
Abstract:
Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been shown to increase coronary artery disease (CAD) risk but the data on systemic sclerosis (SSc) is unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing CAD risk in patients with SSc versus non-SSc participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random effect, generic inverse variance method. Four studies were identified and included in our data analysis. The pooled risk ratio of CAD in patients with SSc was 1.82 (95 % CI, 1.40 to 2.36). The statistical heterogeneity of this meta-analysis was moderate with an I (2) of 73 %. Our study demonstrated a statistically significant increased CAD risk among patients with SSc.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Rheumatic Heart Disease I: Introduction